Approved medicines in Montenegro — L — Antineoplastic and immunomodulating agents (470)
- SUNITINIB ZENTIVAsunitinibRxCapsule, hard, 50mgRemedica Ltd., Cyprus
- SUNITINIB ZENTIVAsunitinibRxCapsule, hard, 12.5mgRemedica Ltd., Cyprus
- SUTENTsunitinibRxCapsule, hard, 12.5mgPfizer Italia S.r.l., Italy
- SUTENTsunitinibRxCapsule, hard, 50mgPfizer Italia S.r.l., Italy
- SUTENTsunitinibRxCapsule, hard, 25mgPfizer Italia S.r.l., Italy
- SUTIREMsunitinibRxCapsule, hard, 12.5mgRemedica Ltd., Cyprus
- SUTIREMsunitinibRxCapsule, hard, 25mgRemedica Ltd., Cyprus
- SUTIREMsunitinibRxCapsule, hard, 50mgRemedica Ltd., Cyprus
- SyrlenoeverolimusRxTablet, 5mgAlkaloid AD Skopje, North Macedonia
- SyrlenoeverolimusRxTablet, 2.5mgAlkaloid AD Skopje, North Macedonia
- SyrlenoeverolimusRxTablet, 10mgAlkaloid AD Skopje, North Macedonia
- TAFINLARdabrafenibRxCapsule, hard, 50mgNovartis Pharmaceuticals UK Ltd., United Kingdom
- TAFINLARdabrafenibRxCapsule, hard, 75mgNovartis Pharmaceuticals UK Ltd., United Kingdom
- TagrissoosimertinibRxFilm-coated tablet, 40mgAstraZeneca AB, Sweden
- TagrissoosimertinibRxFilm-coated tablet, 80mgAstraZeneca AB, Sweden
- TALVEYtalquetamabRxSolution for injection, 2mg/mlJanssen Biologics B.V., Netherlands
- TALVEYtalquetamabRxSolution for injection, 40mg/mlJanssen Biologics B.V., Netherlands
- TASIGNAnilotinibRxCapsule, hard, 150mgNovartis Pharmaceutical Manufacturing LLC, Slovenia
- TASIGNAnilotinibRestrictedCapsule, hard, 200mgNovartis Pharma Stein AG, Switzerland
- TECENTRIQatezolizumabRxConcentrate for solution for infusion, 1200mgF. Hoffmann-La Roche AG, Switzerland